ETHICAL ISSUES OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH INTELLECTUAL DISABILITIES

Na minha lista:

Detalhes bibliográficos
Autor principal:	RAGHAVAN, R.
Outros Autores:	PATEL, P.
Formato:	Livro
Idioma:	espanhol inglês
Assuntos:	Calidad de la atención Discapacidad intelectual Ética Fármacos Psicótropos Recetas médicas Recomendaciones Reino Unido Toma de decisiones Trastornos de la conducta Tratamiento médico Discapacidad Documental
Acesso em linha:	Path Enlace web pago
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados: ETHICAL ISSUES OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH INTELLECTUAL DISABILITIES

Quick Look
RECEIPT OF PSYCHOTROPIC MEDICATION BY PEOPLE WITH INTELLECTUAL DISABILITY IN RESIDENTIAL SETTINGS
Quick Look
Psychotropic medications and the transition into care: a national data linkage study
Quick Look
DEMENTIA AND USE OF PSYCHOTROPIC MEDICATION IN NON-"ELDERLY MENTALLY INFIRM" NURSING HOMES IN SOUTH EAST ENGLAND
Quick Look
THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
Quick Look
PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
Quick Look
Do people with intellectual disabilities understand their prescription medication? A scoping review
Quick Look
What do people with intellectual disabilities, their family members and paid carers understand about psychotropic medication? A rapid review
Quick Look
SOLO EN GIPUZKOA SE PRESCRIBEN CERCA DE 50.000 RECETAS AL MES DE TRANQUILIZANTES Y SOMNIFEROS
Quick Look
THE GLOBAL DIVERSION OF PHARMACEUTICAL DRUGS. NON MEDICAL USE AND DIVERSION OF PSYCHOTROPIC PRESCRIPTION DRUGS IN NORTH AMERICA: A REVIEW OF SOURCING ROUTES AND CONTROL MEASURES
Quick Look
INTERNATIONAL GUIDE TO PRESCRIBING PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES
Quick Look
PSYCHOTROPIC PRESCRIBING PRACTICES OF PAEDIATRICIANS IN THE UK
Quick Look
PRACTICAL GUIDELINES FOR THE USE OF NEW GENERATION ANTIPSYCHOTIC DRUGS (EXCEPT CLOZAPINE) IN ADULT INDIVIDUALS WITH INTELLECTUAL DISABILITIES
Quick Look
Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour
Quick Look
GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
Quick Look
NONMEDICAL USE OF PRESCRIPTION STIMULANTS IN THE INITED STATES
Quick Look
Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el período 2000-2011
Quick Look
People with intellectual disabilities and their experience of medication: A narrative literature review
Quick Look
Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients
Quick Look
The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial
Quick Look
The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes
Quick Look
ETHICAL USE OF MEDICATION TO MANAGE IMMINENT DISTURBED/VIOLENT BEHAVIOUR IN ADULTS WITH INTELLECTUAL DISABILITIES. EN: ETHICAL APPROACHES TO PHYSICAL INTERVENTIONS. VOLUME II: CHANGING THE AGENDA
Quick Look
EXPLICIT, EVIDENCE-BASED CRITERIA TO ASSESS THE QUALITY OF PRESCRIBING TO ELDERLY NURSING HOME RESIDENTS
Quick Look
AN EVALUATION OF AN ADAPTED U.S. MODEL OF PHARMACEUTICAL CARE TO IMPROVE PSYCHOACTIVE PRESCRIBING FOR NURSING HOME RESIDENTS IN NORTHERN IRELAND (FLEETWOOD NORTHERN IRELAND STUDY)
Quick Look
Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities